Bengaluru-Based Eyestem Raises $6.4 Million in Series A Round
Bengaluru-based cell therapy company Eyestem has raised $6.4 million in its Series A round led by three pharma giants – Biological E, Alkem, Natco and...
Tag : Natco
Natco Pharma slides 8% on weak Q4 results
Natco Pharma shares hit a new low of Rs 482, down 8 percent on the BSE in early morning trade, after the company reported a...
Natco partner’s multiple sclerosis injection receives USFDA approval
The US Food and Drug Administration(USFDA), has given approval to Natco Pharma’s marketing partner,Mylan’s Glatiramer Acetate injection used for treating relapsing forms of multiple sclerosis(MS)....